Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger
Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
HTL | change in substantial holding | 06/12/04 | 0 | 422 | |||
|
|||||||
HTL | up 5% on good vol,anyone follow this one | 16/02/04 | 0 | 384 | |||
|
|||||||
HTL | anyone follow this one?(up 13% 2day) | 19/01/04 | 0 | 398 | |||
|
|||||||
HTL | **take over rumour (bunnings)** | 19/01/04 | 0 | 1.0K | |||
|
|||||||
HTL | for s.d | 16/01/04 | 0 | 423 | |||
|
|||||||
HTL | firing!!! | 16/01/04 | 1 | 650 | |||
|
|||||||
HTL | dont say i didn't tell ya's again! | 28/10/03 | 20 | 4.3K | |||
|
|||||||
HTL | worth a punt! | 27/10/03 | 0 | 714 | |||
|
See All Discussions